| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Skye Bioscience, Inc. | Chief Financial Officer | Common Stock | 166K | $830K | $4.99 | Nov 18, 2024 | Direct |
| Skye Bioscience, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 125K | Oct 28, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | Nov 15, 2024 | 2 | -$217K | 4 | Nov 19, 2024 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Oct 28, 2024 | 1 | $0 | 4 | Oct 30, 2024 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Feb 29, 2024 | 2 | $0 | 4/A | Mar 4, 2024 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Feb 29, 2024 | 2 | $0 | 4 | Mar 1, 2024 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Nov 6, 2023 | 2 | $0 | 4 | Nov 6, 2023 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Aug 25, 2023 | 2 | $0 | 4 | Aug 29, 2023 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Dec 14, 2021 | 2 | $0 | 4 | Dec 16, 2021 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Oct 4, 2021 | 1 | $0 | 4 | Oct 5, 2021 | Chief Financial Officer |
| SKYE | Skye Bioscience, Inc. | Oct 4, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Chief Financial Officer |